Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sigrid Carlsson

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
BJU International|September 3, 2015
A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)Marco Randazzo, Alexander Müller, Sigrid Carlsson, et al.
Journal of the National Cancer Institute|July 26, 2022
Response to TakahashiLeonardo D Borregales, Gina DeMeo, Xiangmei Gu, et al.
Journal of the National Cancer Institute|March 29, 2022
Grade Migration of Prostate Cancer in the United States During the Last DecadeLeonardo D Borregales, Gina DeMeo, Xiangmei Gu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2019
Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsyGregory T Chesnut, Piotr Zareba, Daniel D Sjoberg, et al.
European Urology|August 16, 2011
Towards an optimal interval for prostate cancer screeningPim J van Leeuwen, Monique J Roobol, Ries Kranse, et al.
European Urology|May 21, 2013
Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section RotterdamSigrid Carlsson, Alexandra Maschino, Fritz Schröder, et al.
European Urology|September 25, 2016
Corrigendum re: "Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial" [Eur Urol 2016;70:566-73]Anna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
European Urology|January 4, 2016
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening TrialAnna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
Journal of Surgical Oncology|September 1, 2023
Reducing opioid prescribing after ambulatory breast reconstruction surgeryNkechi J Fearon, Joey Kurtzman, Nicole Benfante, et al.
British Journal of Cancer|November 18, 2016
Impact of cause of death adjudication on the results of the European prostate cancer screening trialStephen D Walter, Harry J de Koning, Jonas Hugosson, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
BJU International|September 3, 2015
A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)Marco Randazzo, Alexander Müller, Sigrid Carlsson, et al.
Journal of the National Cancer Institute|July 26, 2022
Response to TakahashiLeonardo D Borregales, Gina DeMeo, Xiangmei Gu, et al.
Journal of the National Cancer Institute|March 29, 2022
Grade Migration of Prostate Cancer in the United States During the Last DecadeLeonardo D Borregales, Gina DeMeo, Xiangmei Gu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 4, 2019
Patient-reported pain, discomfort, and anxiety during magnetic resonance imaging-targeted prostate biopsyGregory T Chesnut, Piotr Zareba, Daniel D Sjoberg, et al.
European Urology|August 16, 2011
Towards an optimal interval for prostate cancer screeningPim J van Leeuwen, Monique J Roobol, Ries Kranse, et al.
European Urology|May 21, 2013
Predictive value of four kallikrein markers for pathologically insignificant compared with aggressive prostate cancer in radical prostatectomy specimens: results from the European Randomized Study of Screening for Prostate Cancer section RotterdamSigrid Carlsson, Alexandra Maschino, Fritz Schröder, et al.
European Urology|September 25, 2016
Corrigendum re: "Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial" [Eur Urol 2016;70:566-73]Anna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
European Urology|January 4, 2016
Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening TrialAnna Grenabo Bergdahl, Ulrica Wilderäng, Gunnar Aus, et al.
Journal of Surgical Oncology|September 1, 2023
Reducing opioid prescribing after ambulatory breast reconstruction surgeryNkechi J Fearon, Joey Kurtzman, Nicole Benfante, et al.
British Journal of Cancer|November 18, 2016
Impact of cause of death adjudication on the results of the European prostate cancer screening trialStephen D Walter, Harry J de Koning, Jonas Hugosson, et al.
Pageof 10